Amniotic fluid embolism is a rare but serious childbirth emergency. It happens when amniotic fluid or fetal cells enter the parent’s bloodstream and trigger a severe reaction. People with amniotic fluid embolism may have sudden shortness of breath, low blood pressure, confusion, or seizures, and doctors may see heavy bleeding. It occurs during labor, delivery, or soon after, and urgent care in an intensive setting is standard. Mortality is higher than most pregnancy complications, but rapid treatment with oxygen, blood products, blood pressure support, and critical care has improved survival.
Overview
Amniotic fluid embolismSymptoms
Amniotic fluid embolism usually starts suddenly during labor or soon after birth. Early symptoms of amniotic fluid embolism include abrupt shortness of breath, chest pain, anxiety, confusion, or seizures, followed by fainting and heavy bleeding.
Outlook and prognosis
Most people who experience amniotic fluid embolism need rapid, intensive care, often in an ICU, and recovery can take weeks to months. Outcomes vary: some make a strong recovery, while others may have lasting effects like fatigue, memory changes, or organ injury. Early recognition, coordinated obstetric and critical care, and rehabilitation improve the outlook.
Causes and risk factors
Amniotic fluid embolism likely involves a sudden inflammatory and clotting response after fetal or placental material reaches the bloodstream. Risk increases with induction, cesarean/operative delivery, placenta previa or abruption, and preeclampsia. No confirmed genetic, environmental, or lifestyle risks.
Genetic influences
Genetics currently appears to play little to no role in amniotic fluid embolism. Most cases seem sporadic, linked to pregnancy-related factors rather than inherited variants. Family history is not considered a meaningful risk indicator at this time.
Diagnosis
Amniotic fluid embolism is diagnosed when sudden collapse, breathing failure, and heavy bleeding occur during labor or shortly after birth. There’s no single test. Doctors use blood tests and imaging to confirm a clotting problem and rule out other emergencies.
Treatment and drugs
Treatment for amniotic fluid embolism focuses on rapid stabilization: oxygen, breathing support, IV fluids, and medications to support blood pressure and heart function. Doctors treat severe bleeding with blood products and manage clotting problems. An emergency delivery may be needed.
Symptoms
Symptoms of amniotic fluid embolism start abruptly during labor, birth, or shortly after. People sometimes describe early symptoms of amniotic fluid embolism as sudden shortness of breath, chest pain, or a sense that something is very wrong. Early on, this might look like a rapid change from feeling fine to feeling faint, confused, and short of breath. It’s a medical emergency that needs immediate care.
You may feel like you can’t get enough air, even at rest. Breathing may become fast and shallow within minutes. This is common at the very start of amniotic fluid embolism.
Sharp chest pain or a squeezing pressure can appear out of nowhere. It may worsen with breathing or feel like heaviness in the center of the chest.
Lightheadedness can build quickly, as if you might pass out. Sitting or lying down may not relieve the dizziness.
Thinking can feel foggy, and it may be hard to answer simple questions. Restlessness or a sudden sense of panic can set in.
How people usually first notice Amniotic fluid embolism?
Amniotic fluid embolism is usually first noticed suddenly during labor or right after delivery: a birthing parent may feel abrupt shortness of breath, chest heaviness, or a sense that something is very wrong, followed quickly by fainting or seizures. Clinicians often see a rapid drop in blood pressure, oxygen levels, and heart rate in the parent, and the baby’s heart tracing may show distress; heavy bleeding or problems with clotting can follow within minutes. These first signs of amniotic fluid embolism are dramatic and medical teams treat them as an emergency the moment they appear.
Types of Amniotic fluid embolism
Amniotic fluid embolism is a rare, life-threatening obstetric emergency that can unfold suddenly during labor, delivery, or shortly after birth. People with this condition often move through recognizable clinical phases that affect the heart, lungs, blood clotting, and sometimes the brain. Sometimes, symptoms cluster together in recognizable ways. Knowing the main types of presentations can help families and clinicians talk through the early symptoms of amniotic fluid embolism and what may come next.
Cardiorespiratory collapse
This pattern starts abruptly with severe shortness of breath, low oxygen levels, and a sudden drop in blood pressure. It can progress to cardiac arrest within minutes if not treated. Intensive support for breathing and circulation is usually needed right away.
DIC-dominant course
Here, bleeding and abnormal clotting take center stage, known medically as disseminated intravascular coagulation. People may have heavy vaginal bleeding, oozing from IV sites, and bruising as clotting factors are rapidly used up. Transfusions and targeted blood products are often required.
Two-phase presentation
Symptoms begin with a sudden heart–lung crisis, then shift into a bleeding phase hours later. The first phase involves low oxygen, shock, or irregular heart rhythm, followed by widespread clotting problems. The timing and intensity can vary between individuals.
Neurologic-predominant features
Confusion, agitation, seizures, or decreased responsiveness stand out early, sometimes alongside milder breathing symptoms. These signs reflect reduced oxygen delivery to the brain during the initial event. Quick stabilization of airway and blood pressure can reduce further brain injury.
Atypical postpartum onset
Symptoms appear after delivery rather than during labor, sometimes during cesarean recovery or shortly after a vaginal birth. People may first notice sudden shortness of breath or heavy bleeding while in the recovery area. Staff often recognize this pattern quickly due to the abrupt change from a stable postpartum course.
What genetics can tell you about symptoms
Certain gene variations affecting blood clotting and inflammation, like in SERPINE1 or PAI-1 pathways, may raise susceptibility to amniotic fluid embolism. These changes can tilt the body toward abnormal clots and intense immune reactions, worsening breathing failure, shock, or bleeding.
Causes and risk factors
Amniotic fluid embolism happens when amniotic material enters the bloodstream of someone giving birth and triggers a sudden immune reaction. It often occurs without early symptoms of amniotic fluid embolism and is more likely during labor or within the first hours after birth. Risk can rise with labor induction, cesarean or assisted delivery, and procedures that disrupt the uterus, but having risk factors doesn’t mean you’ll definitely develop the condition. Placental problems, preeclampsia, uterine rupture, and excess fluid around the baby also raise risk. There is no proven inherited cause, and lifestyle factors seem to play little role.
Environmental and biological risk factors
Amniotic fluid embolism is rare, sudden, and happens around labor, birth, or shortly after. Doctors often group risks into internal (biological) and external (environmental). Knowing the risk factors can help you and your team act fast if early symptoms of amniotic fluid embolism appear. Most births go smoothly, but it helps to understand what can raise the chance.
Pregnancy at age 35 or older slightly increases risk. Age-related changes in the uterus and placenta may make it easier for fluid or cells to enter the bloodstream.
Placental problems that disrupt the boundary between mother and baby can raise the chance of amniotic material entering the blood. Conditions like placenta previa or placental abruption create more pathways for amniotic fluid to reach the circulation. These conditions have been linked with amniotic fluid embolism.
High blood pressure disorders inflame and stress blood vessels. This can make the barrier between uterus and bloodstream more fragile. That increased fragility may contribute to amniotic fluid embolism.
Carrying twins or more stretches the uterus and increases placental surface area. Greater surface area and pressure during labor can provide more opportunities for amniotic contents to enter the blood.
Genetic risk factors
There is no confirmed genetic cause of amniotic fluid embolism (AFE), and no single gene or inherited pattern has been linked to it. At this time, there are no validated genetic risk factors for amniotic fluid embolism, and family history usually does not predict who will be affected. Research has explored whether differences in immune or clotting pathways might influence susceptibility, but findings are limited and not used for screening. Risk is not destiny—it varies widely between individuals.
No proven gene: No single gene has been shown to cause AFE. Studies have not identified a consistent inherited pattern.
Family history: AFE is not known to run in families. Having a relative with AFE does not meaningfully change personal risk.
Immune pathway genes: Small studies suggest differences in immune signaling may relate to susceptibility. Evidence remains preliminary and is not used in clinical care.
Complement variants: Differences in complement and inflammation genes are under study. No specific variant is validated to predict AFE.
Coagulation genes: Inherited differences in clotting or fibrinolysis may influence bleeding severity if AFE occurs. They have not been shown to trigger AFE.
Fetal maternal factors: Genetic features of the fetus may shape how the mother’s immune system responds. No fetal genotype is a confirmed risk factor for AFE.
Tissue compatibility genes: Variations in tissue-matching genes may affect immune responses during pregnancy. Current data are inconsistent and not used for screening.
Lifestyle risk factors
Amniotic fluid embolism (AFE) is a rare obstetric emergency and is not caused by lifestyle choices. However, certain behaviors and decisions can influence how likely you are to encounter medical situations (like inductions or cesareans) that are associated with AFE. Evidence is limited and mostly indirect, so these factors should be viewed as ways to optimize overall pregnancy care rather than guarantees of prevention. Below are lifestyle risk factors for Amniotic fluid embolism discussed in that context.
Having children at an older age is linked with higher rates of labor interventions and complications that are associated with AFE. Planning timing of pregnancy is personal, but understanding these links can inform discussions with your clinician.
Achieving a healthy weight before pregnancy can lower risks of preeclampsia and cesarean delivery, both linked with AFE in observational studies. Gradual, sustainable nutrition and activity changes before conception may reduce exposure to AFE-associated scenarios.
Regular prenatal visits help detect placental problems and hypertensive disorders early, which can lead to fewer urgent interventions associated with AFE. Following care plans may reduce escalation to high-risk procedures during labor.
Choosing elective induction or cesarean without a clear medical reason can increase exposure to procedures linked with AFE. Shared decision-making about timing and mode of delivery may help minimize unnecessary intervention-related risk.
Risk prevention
Amniotic fluid embolism is rare and unpredictable, so there’s no way to fully prevent it. Prevention is about lowering risk, not eliminating it completely. Practical steps focus on safer labor and delivery, choosing the right setting, and fast recognition of early symptoms of amniotic fluid embolism. Planning ahead with your maternity team can help reduce complications if it happens.
Go over factors like placenta problems, high blood pressure in pregnancy, multiples, or prior uterine surgery. Knowing your risks can guide which preventive steps matter most.
Choose a hospital with an experienced obstetric, anesthesia, and critical care team, plus rapid access to blood products. Being in a well-prepared unit can shorten the time to lifesaving care if amniotic fluid embolism occurs.
Avoid inductions, internal monitors, or other interventions unless there’s a clear medical reason. Fewer procedures mean fewer opportunities for fluid to enter the bloodstream during labor.
If induction is needed, clinicians use the lowest effective medication dose and follow safety protocols. Close monitoring helps catch early symptoms of amniotic fluid embolism so treatment can begin quickly.
Transmission
Amniotic fluid embolism (AFE) is not an infection and cannot be transferred between people. It happens as a rare, sudden reaction during labor, delivery, or shortly after birth when amniotic fluid or fetal material enters the bloodstream of the person giving birth, triggering an overwhelming immune and clotting response.
Partners, newborns, other patients, and healthcare staff are not at risk—there is no airborne, sexual, blood, or breastfeeding transmission of amniotic fluid embolism. If you’re wondering how contagious is amniotic fluid embolism, it isn’t, and it isn’t inherited either.
When to test your genes
Consider genetic testing only if you have a personal or strong family history of bleeding or clotting disorders, since inherited factors can influence pregnancy-related risks but do not predict amniotic fluid embolism itself. Routine gene testing is not recommended for amniotic fluid embolism. Discuss tailored testing with your obstetrician or a genetic counselor.
Diagnosis
Amniotic fluid embolism is usually recognized in the middle of labor or shortly after birth when a sudden collapse happens and care teams move fast. Understanding how amniotic fluid embolism is diagnosed centers on the pattern of symptoms, timing around delivery, and ruling out other emergencies. Doctors usually begin with a rapid bedside assessment while starting life-saving treatment. Tests then help confirm the picture and exclude look-alike conditions.
Teams look for a sudden drop in blood pressure, trouble breathing, and changes in mental status that appear during labor, delivery, or within minutes to hours after birth. Bleeding and bruising from clotting problems often follow quickly. This timing helps separate it from other causes.
Heart rate, blood pressure, and oxygen levels are tracked second by second. A sudden need for high oxygen or medications to support blood pressure adds to the concern for amniotic fluid embolism. Response to supportive care is also noted.
Urgent blood work checks platelets and clotting times to detect a fast-moving clotting disorder (disseminated intravascular coagulation). Falling fibrinogen with prolonged PT/INR and PTT supports the diagnosis. These results can guide transfusions.
A blood gas test measures oxygen and acid–base balance. Low oxygen and rising acid levels are common when the lungs and heart are under strain. Results help adjust breathing support.
Stages of Amniotic fluid embolism
Amniotic fluid embolism often unfolds very quickly, typically in two phases during labor, delivery, or shortly afterward. Identifying the cause is the starting point for the right care. Knowing the early symptoms of amniotic fluid embolism—sudden shortness of breath, a rapid drop in blood pressure, confusion, or seizure—can help teams act fast.
Phase 1
Cardio‑respiratory collapse: Breathing can suddenly become difficult, with blue lips or fingertips, and blood pressure may crash. People may feel faint, confused, or have a seizure while monitors show the baby in distress.
Phase 2
Severe bleeding: Once stabilized, heavy bleeding can follow due to a sudden clotting problem that the care team sees in blood tests. This hemorrhagic phase of amniotic fluid embolism may include uterine atony and bleeding from IV sites or surgical incisions.
Outlook and prognosis
Looking at the long-term picture can be helpful. Amniotic fluid embolism (AFE) is a sudden, life‑threatening event, and the hours to days around it are the most critical. Survival has improved in recent years with rapid hospital care, but AFE still carries a significant risk. Reported maternal mortality ranges roughly from 20% to 40% worldwide, depending on how quickly bleeding, heart strain, and breathing failure are treated and on the resources available at the birth setting. Babies can also be affected if oxygen is limited during the event; newborn outcomes depend on how fast resuscitation and delivery occur.
For those who survive the acute crisis, recovery can vary widely. Some people recover over weeks with no lasting problems, while others have complications like organ injury, neurologic changes, or post‑intensive care syndrome that affect memory, sleep, and energy. Many people ask, “What does this mean for my future?”, and most who had AFE go on to live full lives, though they may need follow‑up for clotting issues, heart function, or emotional health. Another pregnancy is possible for some, but it should be planned with a high‑risk obstetric team; the overall chance of AFE happening again appears low, yet data are limited, so individualized counseling is important.
When thinking about the future, it helps to focus on early rehabilitation and mental health support, since post‑traumatic stress, anxiety, and depression are not uncommon after AFE. Early care can make a real difference in managing fatigue, memory changes, and the everyday impact of recovery. If you’re wondering about early symptoms of amniotic fluid embolism in a past birth or a future pregnancy, be aware that AFE typically starts abruptly during labor or soon after delivery, so prevention is not well defined and swift recognition is key. Talk with your doctor about what your personal outlook might look like, including plans for monitoring, family planning, and ways to lower general pregnancy risks in the future.
Long-term effects
Amniotic fluid embolism is a rare childbirth emergency. While early symptoms of amniotic fluid embolism appear suddenly during labor or soon after birth, some survivors face ongoing effects that can touch thinking, breathing, heart health, and emotional well-being. Long-term effects vary widely, and many make a strong recovery with time and rehabilitation. Outlook depends on the severity of the initial event, the need for transfusions or surgery, and how quickly oxygen and circulation were restored.
Some people notice problems with memory, attention, or processing speed after amniotic fluid embolism. These thinking changes often reflect brief periods of low oxygen to the brain. Improvement can continue for months or even years.
A small number develop seizures if the brain was injured during the event. This may require long-term monitoring and treatment. Many remain seizure-free with time.
Shortness of breath or lower exercise tolerance can linger after lung injury. This is more likely if there was pneumonia or ARDS during intensive care. Many gradually regain capacity.
The heart muscle can be temporarily weakened by shock, leading to fatigue, chest discomfort, or palpitations. Most people see function improve as the body heals. Ongoing follow-up may be needed after amniotic fluid embolism.
How is it to live with Amniotic fluid embolism?
Moments can change in a heartbeat with amniotic fluid embolism, but the day-to-day story is usually about recovery after an emergency—healing from birth, processing a frightening experience, and rebuilding strength while watching for lingering issues like fatigue, shortness of breath, memory or concentration changes, and anxiety. Many who survive spend weeks to months regaining stamina and confidence, sometimes needing physical therapy, counseling, or support for heart or lung recovery, and follow-up to manage blood clotting or organ effects. Partners, family, and friends often carry their own worry from the crisis and may need clear updates and support as they help with newborn care, transportation to appointments, and rest breaks. With coordinated postpartum care, mental health support, and a practical plan for gradual activity, many families find steady ground again and grow more secure with time.
Treatment and drugs
Amniotic fluid embolism is a medical emergency, so treatment focuses on rapid stabilization in an intensive care setting. Doctors first support breathing and blood pressure with oxygen, a breathing machine if needed, IV fluids, and medicines that tighten blood vessels and help the heart pump; blood products are given to treat heavy bleeding and problems with clotting. You might picture this as a team effort between you and your doctor, with obstetric, anesthesia, critical care, and transfusion specialists working together. If the baby has not yet been delivered, the team may perform an urgent birth (vaginal or cesarean) to improve outcomes for both parent and baby, while continuing life‑support measures. Recovery care can include medications to prevent clots, treatments for organ support (such as dialysis if the kidneys are affected), and close monitoring for complications after the crisis has passed.
Non-drug treatment
Amniotic fluid embolism is a sudden, life‑threatening obstetric emergency, so treatment focuses on fast, coordinated support to protect breathing, circulation, and vital organs. Alongside medicines, non-drug therapies often stabilize the body while doctors address bleeding and low oxygen. Because early symptoms of amniotic fluid embolism can appear suddenly—like severe shortness of breath, confusion, and a sharp drop in blood pressure—teams act within minutes.
High‑flow oxygen is given right away to raise blood oxygen levels. This helps protect the brain and heart during the crisis.
A breathing tube may be placed to secure the airway. A ventilator then supports breathing and keeps oxygen and carbon dioxide at safe levels.
Tilting the body slightly to the left can improve blood flow back to the heart in late pregnancy. This position also eases pressure on the large blood vessels.
Large IV lines deliver fluids quickly to support blood pressure and circulation. This buys time while the team controls bleeding and stabilizes the heart.
Your genes may have an impact on how drugs work for you
In rare emergencies like amniotic fluid embolism, genes can influence how quickly your body clears medicines and how strongly you respond to drugs for blood pressure, clotting, and pain. Clinicians focus on rapid, life‑saving treatment; genetics rarely change immediate care.
Pharmacological treatments
Treatment for amniotic fluid embolism focuses on fast stabilization—raising blood pressure, supporting the heart and lungs, and controlling heavy bleeding. Drugs that target symptoms directly are called symptomatic treatments. Teams act within minutes, often using several medicines together based on how your circulation, breathing, and bleeding respond. Choices can shift quickly as the situation evolves.
Quickly treats life‑threatening drops in blood pressure and the sudden allergic‑like reaction that can occur in amniotic fluid embolism. Rapid use when early symptoms of amniotic fluid embolism appear can be lifesaving. It’s often given during resuscitation to restore circulation.
First‑line medicine to raise blood pressure in shock and keep vital organs perfused. Dosing may be increased or lowered gradually to balance blood pressure and side effects. It is typically delivered by continuous infusion in intensive care.
Supports the heart’s pumping when the right side strains from sudden lung pressure. This can improve blood flow to the body while other treatments take effect. It is adjusted closely based on heart ultrasound and blood pressure.
Helps stabilize clots and reduce heavy bleeding by slowing clot breakdown. Given early, it can cut blood loss while transfusion is arranged. It is used alongside surgical and supportive steps.
Genetic influences
Many people ask whether amniotic fluid embolism is genetic or tends to run in families. It’s natural to ask whether family history plays a role. Current research suggests amniotic fluid embolism (AFE) is not an inherited disorder, and no specific gene has been shown to cause it. AFE appears to happen as a rare, sudden immune and clotting reaction in pregnancy, rather than a trait passed from parent to child. Having a relative with AFE does not reliably predict your risk, and genetic testing is not recommended for this condition. Scientists continue to explore whether certain immune or blood‑clotting differences might affect who is impacted or how severe it becomes, but evidence is limited and not used to guide care today.
Is Amniotic fluid embolism genetic?
Genetics currently appears to play little to no role in amniotic fluid embolism. Most cases seem sporadic, linked to pregnancy-related factors rather than inherited variants. Family history is not considered a meaningful risk indicator at this time.
Pharmacogenetics—how genetics influence drug effects
Treatment for amniotic fluid embolism is an emergency and follows set hospital protocols. In the heat of resuscitation, genetics rarely changes the immediate steps, but it can influence how someone responds to certain medicines given during or after care. Genetic testing can sometimes identify how your body handles specific pain relievers, sedatives, or blood thinners. For example, some people convert codeine to its active form very quickly or very slowly, which can raise the risk of side effects or make pain control too weak. Rare differences in the enzyme that breaks down a commonly used muscle relaxant during anesthesia can cause unusually long paralysis afterward, so tell your team if you or close relatives have had that experience. If later anticoagulation is needed—for instance with warfarin after a clot or while supported by a heart–lung machine—gene‑guided dosing tools may help set a safer starting dose, always paired with careful blood testing. Overall, genes are only part of the picture; clinicians also rely on your medical history, organ function, and real‑time response when choosing and adjusting medications used to treat amniotic fluid embolism.
Interactions with other conditions
During pregnancy and birth, other health issues can shape how amniotic fluid embolism (AFE) shows up and how quickly it escalates. Doctors call it a “comorbidity” when two conditions occur together. Hypertensive disorders like preeclampsia and placental problems (such as placenta previa or abruption) are linked with AFE and can intensify its hallmark issue—sudden problems with blood clotting—making bleeding harder to control. Heavy postpartum bleeding can then feed into a cycle where clotting factors are used up, so managing hemorrhage becomes more complex when AFE is present. Preexisting heart or lung disease, including cardiomyopathy or severe asthma, may lower the body’s reserve and worsen the breathing failure and shock that can occur with AFE. Sepsis, severe allergic reactions, and blood clots in the lungs can look similar to early symptoms of amniotic fluid embolism, so clinicians often evaluate for these conditions at the same time to avoid delays in care.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described sudden collapse during labor or shortly after birth, with shortness of breath, seizures, or severe bleeding that seemed to come out of nowhere. Families and communities once noticed patterns: a delivery going normally, then minutes later a frightening turn that caregivers struggled to explain. Today, we understand many of these accounts likely reflected amniotic fluid embolism, a rare obstetric emergency.
First described in the medical literature as a puzzling reaction during childbirth in the early 20th century, amniotic fluid embolism was initially defined by what doctors saw at the bedside—sudden breathing failure, shock, and coagulopathy—because there were no tests to confirm it during life. With each decade, pathologists and clinicians compared cases, linking these features with material from the amniotic sac entering the mother’s bloodstream and triggering a severe inflammatory and clotting response. Early reports focused on autopsy findings; later, careful tracking of living patients showed that rapid recognition and supportive care could improve survival.
As medical science evolved, the way the condition was understood changed. What was once thought to be a simple “blockage” of the lungs is now recognized as a complex cascade involving the heart, lungs, and the body’s clotting system. Advances in critical care, anesthesia, blood banking, and obstetric teamwork shifted outcomes. Standardized case definitions were proposed to separate amniotic fluid embolism from other causes of sudden collapse in pregnancy, helping researchers study it more reliably across hospitals and countries.
In recent decades, awareness has grown that amniotic fluid embolism can occur during labor, cesarean birth, induction, or even in the first minutes after delivery, and that symptoms can vary. Some people develop abrupt breathing trouble and low blood pressure; others present first with heavy bleeding due to a clotting disorder. Registries and national audits in the US and EU have helped clarify early symptoms of amniotic fluid embolism and highlighted the importance of fast, coordinated care.
From early theories to modern research, the story of amniotic fluid embolism reflects steady progress built on careful observation. While it remains unpredictable and rare, hospitals now prepare with drills, rapid transfusion protocols, and multidisciplinary response plans. Knowing the condition’s history helps explain why clinicians act quickly and broadly—supporting breathing and circulation, correcting clotting problems, and watching closely for heart strain—because those steps have repeatedly been linked with better chances of recovery.